← FDA Drug Approvals (Drugs@FDA)
ILOPROST
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: REGCON HOLDINGS · Approved 2026-07-10
Drug application
- FDA Application #
ANDA214997- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ILOPROST
- Generic name
- Iloprost
- Active ingredients
- ILOPROST
- Dosage form
- SOLUTION
- Route
- INHALATION
- Marketing status
- Prescription
- Sponsor
- REGCON HOLDINGS
- First approval
- 2026-07-10
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown